Prophylactic Inhaled Pattern Recognition Receptor Agonists Reprogram Lung Epithelial Response and Prevent Type 2 Allergic Inflammation

Read full text Summarise with VIRAT
Authors: M. Ntita, Celine Shuet Lin Kong, Dalia Hassan, Richa Nayak, Jezreel Pantaleón García, Yongxing Wang, Jichao Chen, Scott E. Evans
Cited by: 0
References: 81

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ABSTRACT Prophylactic inhalation of the synergistic agents ODN M362 and Pam2CSK4 (“Pam2ODN”) protects mice against allergic lung disease, including allergic inflammation caused by house dust mite (HDM). By preventing sensitization, Pam2ODN reduces HDM‐induced eosinophilic and lymphocytic inflammation. How Pam2ODN affects interactions among lung epithelial cells, dendritic cells, and T cells to prevent eosinophilic lung inflammation remains unclear. In the present study, we show that a single inhaled dose of Pam2ODN before HDM sensitization reduces airway Th2 polarization without affecting Th1 or Treg responses. Furthermore, Pam2ODN pretreatment inhibits the recruitment of lung monocyte‐derived dendritic cells (moDCs) and conventional Type 2 dendritic cells (DC2s), while preventing the HDM‐induced decrease in conventional Type 1 dendritic cells (DC1s). Bulk RNA‐seq of the whole lung reveals that Pam2ODN pretreatment restricts the expression of proinflammatory transcripts induced by HDM sensitization. This tolerogenic effect is also reflected at the single‐cell level in lung epithelial cells, where proinflammatory transcripts, pathways, and chromatin accessibility are inhibited. These results indicate that Pam2ODN reprograms lung epithelial cells to attenuate allergen‐induced Th2‐promoting cytokines and DCs while maintaining the population of protective DC1s. These findings suggest a strategy to mitigate chronic allergic lung diseases.

Fields of Study & Subjects

Asthma and respiratory diseases Allergic Rhinitis and Sensitization IL-33 ST2 and ILC Pathways

Publication details

Journal / source
European Journal of Immunology
Volume
56
Issue
4
Pages
e70172–e70172
Publication date
27 March 2026
Language
EN